ArticleClinical drug investigation2024

An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom.

Pablo E Bretos-Azcona et al.PubMed ↗Publisher ↗

No numbers read from the abstract.